TECH Stock: Price, Forecast, Financials & AI Analysis

Loading chart...

High

70.980

Open

70.920

VWAP

70.71

Vol

5.48M

Mkt Cap

11.06B

Low

70.540

Amount

387.72M

EV/EBITDA(TTM)

29.42

Total Shares

156.57M

11.04B

EV/OCF(TTM)

37.44

P/S(TTM)

9.17

Bio-Techne Corporation develop, manufacture and sell life science reagents, instruments and services for the research, diagnostics and bioprocessing markets worldwide. The Company’s segments include Protein Sciences segment and Diagnostics and Spatial Biology segment. The Protein Sciences segment is a developer and manufacturer of purified proteins and reagent solutions, most notably cytokines and growth factors, antibodies, immunoassays, biologically active small molecule compounds, tissue culture reagents and T-Cell activation technologies. The Diagnostics and Spatial Biology segment develops and manufactures diagnostic products, including controls, calibrators, blood gas and clinical chemistry controls and other reagents for OEM and clinical customers. This segment also manufactures and sells fully automated multiomic spatial biology instrumentation and advanced tissue-based in-situ hybridization assays (ISH) for research and clinical use.

Events Timeline

(ET)

2026-07-06

09:00:00

Evercore ISI Downgrades Bio-Techne to In Line with $73 Price Target

2026-06-30 (ET)

2026-06-30

07:30:00

Benchmark Downgrades Bio-Techne to Hold After Merck KGaA Acquisition

2026-06-26 (ET)

2026-06-26

17:00:00

Citi Downgrades Bio-Techne to Neutral with $73 Price Target

2026-06-26

08:30:00

Stephens Downgrades Bio-Techne to Equal Weight, Price Target Raised to $73

News

7.0

07-06Globenewswire

Investor Rights Law Firm Investigates Multiple Companies

8.5

07-06Globenewswire

Multiple Companies Under Investigation for Merger Deal Fairness

8.5

07-02PRnewswire

Investor Rights Law Firm Investigates Multiple Companies

8.5

07-02Globenewswire

Investigation into Bio-Techne's Merck Transaction

7.5

07-01NASDAQ.COM

Market Capitalization Comparison of Bio-Techne and Charles River Laboratories

8.5

06-30Globenewswire

Investor Rights Law Firm Investigates Multiple Companies

9 Analyst Rating

Wall Street analysts forecast TECH stock price to rise

6 Buy

3 Hold

0 Sell

Moderate Buy

Current: 0.000

Low

60.00

Averages

66.14

High

72.00

Current: 0.000

Low

60.00

Averages

66.14

High

72.00

HSBC

Rajesh Kumar

Buy

Hold

downgrade

AI Analysis

2026-07-06

New

Reason

HSBC

Rajesh Kumar

Price Target

AI Analysis

2026-07-06

New

downgrade

Buy

Hold

Reason

As previously reported, HSBC analyst Rajesh Kumar downgraded Merck KGaA (MKGAY) to Hold from Buy with a price target of EUR 170, up from EUR 160. The valuation of the recent deal to acquire Bio-Techne (TECH) \"seems rich in our view, and has the potential to be returns accretive in only the most bullish of scenarios,\" the analyst tells investors.

HSBC

Buy

Hold

downgrade

2026-07-06

New

Reason

HSBC

Price Target

2026-07-06

New

downgrade

Buy

Hold

Reason

HSBC downgraded Merck KGaA (MKGAY) to Hold from Buy with a price target of EUR 170, up from EUR 160. The valuation of the recent deal to acquire Bio-Techne (TECH) \"seems rich in our view, and has the potential to be returns accretive in only the most bullish of scenarios,\" the analyst tells investors.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for TECH

Unlock Now

Valuation Metrics

The current forward P/E ratio for Bio-Techne Corp (TECH.O) is 33.78, compared to its 5-year average forward P/E of 39.06. For a more detailed relative valuation and DCF analysis to assess Bio-Techne Corp's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

5Y Average PE

39.06

Current PE

33.78

Overvalued PE

49.14

Undervalued PE

28.98

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

5Y Average EV/EBITDA

28.57

Current EV/EBITDA

26.57

Overvalued EV/EBITDA

35.55

Undervalued EV/EBITDA

21.59

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

5Y Average PS

10.17

Current PS

8.74

Overvalued PS

13.25

Undervalued PS

7.08

Financials

AI Analysis

Annual

Quarterly

Related Community Screener

50$ stocks for a CSP

Intellectia · 73 candidates

Price: $45.00 - $55.00Analyst Consensus: Moderate Buy, Strong BuyRsi Category: moderateBeta: LowRisk, ModerateRiskIs Optionable: TrueMonthly Average Dollar Volume: >= 1,500,000

Ticker

Name

Market Cap$

BAC

Bank of America Corp

367.60B

Verizon Communications Inc

201.89B

CSX

CSX Corp

84.57B

CTSH

Cognizant Technology Solutions Corp

24.95B

EXC

Exelon Corp

47.30B

DVN

Devon Energy Corp

54.44B

qué acción es la que más va a subir hoy

Intellectia · 34 candidates

Price: $5.00 - $150.00Moving Average Relationship: PriceAboveMA20One Day Rise Prob: >= 70One Day Predict Return: >= 2.0%Monthly Average Dollar Volume: >= 1,000,000

Ticker

Name

Market Cap$

TNK

Teekay Tankers Ltd

2.63B

MFC

Manulife Financial Corp

59.04B

YOU

Clear Secure Inc

7.02B

WRB

W R Berkley Corp

24.97B

FOX

Fox Corp

22.87B

FOXA

Fox Corp

25.37B

potential stocks to short

Intellectia · 8 candidates

Market Cap: >= 2.00BRegion: USQuarter Revenue Yoy Growth: <= 0.0%Pe Ttm: >= 30List Exchange: XNYS, XNAS, XASEMoving Average Relationship: PriceBelowMA200Month Price Change Pct: <= $-10.00

Ticker

Name

Market Cap$

CARR

Carrier Global Corp

49.03B

Weyerhaeuser Co

16.74B

TTEK

Tetra Tech Inc

8.81B

TECH

Bio-Techne Corp

8.39B

GGAL

Grupo Financiero Galicia SA

7.30B

BBAR

Banco BBVA Argentina SA

3.08B

stocks likely to surge after market close

Intellectia · 5 candidates

Region: USMoving Average Relationship: PriceAboveMA5One Day Rise Prob: >= 60One Day Predict Return: >= 3.0%News Driver: Positive

Ticker

Name

Market Cap$

AEHR

Aehr Test Systems

1.20B

TECH

Bio-Techne Corp

8.57B

VRE

Veris Residential Inc

1.76B

SNPS

Synopsys Inc

80.61B

EBAY

eBay Inc

37.77B

so what Company is best for me

Intellectia · 79 candidates

Price: $5.00 - $400.00Relative Vol: >= 3List Exchange: XNYS, XNAS, XASEOne Week Rise Prob: >= 65One Week Predict Return: >= 5.0%Monthly Average Dollar Volume: >= 1,000,000

Ticker

Name

Market Cap$

ITGR

Integer Holdings Corp

3.00B

VERX

Vertex Inc

2.12B

SCHW

Charles Schwab Corp

164.81B

SPHR

Sphere Entertainment Co

3.95B

IRON

Disc Medicine Inc

2.42B

CRI

Carter's Inc

1.55B

stocks that predict to rise in one week

Intellectia · 39 candidates

Market Cap: >= 5.00BPrice: $10.00 - $250.00One Week Rise Prob: >= 72One Week Predict Return: >= 3.0%Monthly Average Dollar Volume: >= 1,000,000

Ticker

Name

Market Cap$

CVE

Cenovus Energy Inc

42.47B

SCHW

Charles Schwab Corp

164.81B

NiSource Inc

22.11B

ATO

Atmos Energy Corp

30.06B

CIGI

Colliers International Group Inc

5.69B

RGEN

Repligen Corp

7.62B

whats the next best swing trade

Intellectia · 70 candidates

Rsi Category: moderateMoving Average Relationship: PriceAboveMA20, PriceAboveMA200Month Price Change Pct: $8.00 - $25.00Is Index Component: GSPC, NDXMonthly Average Dollar Volume: >= 2,000,000

Ticker

Name

Market Cap$

CMI

Cummins Inc

78.93B

LRCX

Lam Research Corp

273.74B

Deere & Co

139.45B

PPG

PPG Industries Inc

25.20B

DXCM

Dexcom Inc

28.42B

MHK

Mohawk Industries Inc

7.46B

what stock should I buy this morning

Intellectia · 66 candidates

Price: $10.00 - $200.00List Exchange: XNYS, XNAS, XASEMoving Average Relationship: PriceAboveMA200Week Price Change Pct: $2.00 - $15.00Is Index Component: GSPC, DJI, NDXMonthly Average Dollar Volume: >= 1,000,000

Ticker

Name

Market Cap$

NEE

Nextera Energy Inc

174.63B

IEX

IDEX Corp

14.90B

HST

Host Hotels & Resorts Inc

12.85B

Ingersoll Rand Inc

35.49B

EXC

Exelon Corp

45.46B

TXT

Textron Inc

16.97B

find similar stocks of hims and hers

Intellectia · 208 candidates

Market Cap: 300.00M - 15.00BPs Ratio: <= 15.00Is Optionable: TrueAnnual Revenue Yoy Growth: >= 0.0%

Ticker

Name

Market Cap$

Guardant Health Inc

14.98B

ICLR

ICON PLC

14.12B

PEN

Penumbra Inc

14.03B

SOLV

Solventum Corp

13.94B

SNN

Smith & Nephew PLC

13.91B

NBIX

Neurocrine Biosciences Inc

13.50B

Whales Holding TECH

Portolan Capital Management, LLC

American Capital Management, Inc.

Glenview Capital Management, LLC

Ceredex Value Advisors LLC

Ruane, Cunniff & Goldfarb L.P.

Cresset Asset Management, LLC

Trading Trends

People Also Watch

Frequently Asked Questions

What is Bio-Techne Corp (TECH) stock price today?

The current price of TECH is 70.61 USD — it has decreased -0.44

What is Bio-Techne Corp (TECH)'s business?

What is the price predicton of TECH Stock?

Wall Street analysts forecast TECH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for TECH is66.14 USD with a low forecast of 60.00 USD and a high forecast of 72.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.